New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD)

Molecular and Cellular Endocrinology
Remko HersmusLeendert H J Looijenga

Abstract

Disorders of sex development (DSD), previously known as intersex, refer to congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical. Patients with specific variants of this disorder have an elevated risk for the development of so-called type II germ cell cancers, i.e., the seminomatous and nonseminatous tumors, referred to as germ cell tumors (GCTs). Specifically DSD patients with gonadal dysgenesis or hypovirilization are at risk. A prerequisite for type II GCT formation is the presence of a specific part of the Y chromosome (referred to as the GBY region), with the TSPY gene being the most likely candidate. Also the octamer binding transcription factor OCT3/4 is consistently expressed in all type II GCTs with pluripotent potential, as well as in the precursor lesions carcinoma in situ (CIS) in case of a testis and gonadoblastoma (GB) in the DSD gonad. The actual risk for malignant transformation in individual DSD patients is hard to predict, because of confusing terminology referring to the different forms of DSD, and unclear criteria for identification of the presence of malignant germ cells, especially in young patients. This is specifically due to the phenomenon of delay of germ cel...Continue Reading

References

Nov 1, 1989·Journal of the National Cancer Institute·H Møller
Sep 9, 1972·Lancet·N E Skakkebaek
Jan 1, 1994·Current Topics in Developmental Biology·P J Donovan
Nov 1, 1993·The American Journal of Surgical Pathology·T M Ulbright
Jan 1, 1993·Human Mutation·J R Hawkins
Jan 1, 1993·European Urology·B Gondos
Jun 11, 1996·International Journal of Cancer. Journal International Du Cancer·P W AndrewsP Stern
Nov 1, 1996·Human Molecular Genetics·F SchniedersJ Schmidtke
Dec 17, 1997·Nature Genetics·S BarbauxK McElreavey
Mar 5, 1998·Nature·A SwainR Lovell-Badge
Apr 3, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·N E SkakkebaekJ Müller
Apr 3, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L H LooijengaJ W Oosterhuis
Oct 9, 1998·Cytogenetics and Cell Genetics·K S Reddy, V Sulcova
Jan 28, 1999·Molecular and Cellular Endocrinology·N JossoF Xavier
Aug 5, 1999·Journal of the National Cancer Institute·J AlbanellE Dmitrovsky
Mar 8, 2000·Mechanisms of Development·R AndersonC Wylie
Jun 8, 2001·The Journal of Biological Chemistry·Z ChaiB H Toh
Jun 23, 2001·Molecular and Cellular Endocrinology·R A VeitiaM Fellous
Sep 3, 2002·Mechanisms of Development·Petra HajkovaM Azim Surani
Mar 14, 2003·Journal of Andrology·Jolanta Słowikowska-HilczerKrzysztof Kula
May 20, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J W OosterhuisL H J Looijenga
Sep 27, 2003·Developmental Biology·Anne McLaren
Dec 9, 2003·Nature Biotechnology·Jonathan S DraperPeter W Andrews
Dec 12, 2003·Cancer Cell·Sharon GidekelEli Pikarsky
Jan 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Karel De GendtGuido Verhoeven
Jun 29, 2004·The Journal of Pathology·Friedemann HoneckerLeendert H J Looijenga
Jul 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Erik G PuffenbergerDietrich A Stephan
Oct 16, 2004·EMBO Reports·James KehlerAlexey Tomilin
Nov 9, 2004·Current Opinion in Genetics & Development·Manfred Schartl
Feb 8, 2005·Reproduction : the Official Journal of the Society for the Study of Fertility·Cinzia AllegrucciLorraine Young
Mar 2, 2005·Nature Reviews. Cancer·J Wolter Oosterhuis, Leendert H J Looijenga
Apr 9, 2005·The Journal of Pathology·Jeroen de JongLeendert H J Looijenga
Apr 23, 2005·Cell and Tissue Research·Kristian AlmstrupNiels E Skakkebaek
Nov 8, 2005·The Journal of Pathology·Friedemann HoneckerJ Wolter Oosterhuis

❮ Previous
Next ❯

Citations

Jun 11, 2009·European Journal of Human Genetics : EJHG·Remko HersmusLeendert H J Looijenga
May 10, 2011·Human Molecular Genetics·Peter A KanetskyKatherine L Nathanson
Mar 23, 2013·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Marwah M AbdulkaderMousa A Al-Abbadi
Jan 19, 2012·International Journal of Endocrinology·A Zulfa JuniartoStenvert L S Drop
Jul 28, 2011·Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation·M CoolsL H J Looijenga
Jun 21, 2011·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Rebecca Buell-GutbrodKatja Gwin
Feb 4, 2014·Virchows Archiv : an International Journal of Pathology·Leendert H J LooijengaKatharina Biermann
Feb 6, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Li TianLi Li
May 3, 2014·Annales d'endocrinologie·Martine Cools
Jun 11, 2014·Nature Reviews. Endocrinology·John M HutsonSamuel D Pennell
Jan 21, 2016·Nature Reviews. Urology·Alice FaureYves Heloury
Feb 16, 2010·Journal of Pediatric Urology·Carmen CapitoYves Héloury
Mar 24, 2009·Birth Defects Research. Part C, Embryo Today : Reviews·Yun-Fai Chris LauTatsuo Kido
Nov 25, 2014·Pediatric Blood & Cancer·Kris Ann P SchultzDavid J Vaughn
Jun 15, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Leendert H J LooijengaKatja P Wolffenbuttel
Jul 30, 2014·Seminars in Cancer Biology·Martin A Rijlaarsdam, Leendert H J Looijenga
Feb 9, 2012·International Journal of Endocrinology·Remko HersmusLeendert H J Looijenga
Oct 28, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Laureline LepaisFrédérique Dijoud
Oct 8, 2016·Clinical Genetics·Remko HersmusLeendert H J Looijenga
Mar 24, 2009·Birth Defects Research. Part C, Embryo Today : Reviews·Gert-Jan M van de GeijnLeendert H J Looijenga
Apr 22, 2011·The Journal of Clinical Endocrinology and Metabolism·M CoolsUNKNOWN Mosaicism Collaborative Group
Jun 5, 2013·Journal of Pediatric Endocrinology & Metabolism : JPEM·Payal R PatelPreneet Cheema Brar
Apr 17, 2015·Journal of Pediatric Endocrinology & Metabolism : JPEM·Ayhan AbacıMerih Berberoğlu
Oct 16, 2019·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Borna Relja, Walter Gottlieb Land
Aug 10, 2020·Indian Journal of Pathology & Microbiology·Sujata S GiriyanNahida Afshan Shigli
Sep 5, 2014·Experimental and Therapeutic Medicine·Xue DUYukun Han
Jan 26, 2021·Gynecologic Oncology Reports·Surekha ThakurUttam Kumar Thakur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Best Practice & Research. Clinical Endocrinology & Metabolism
Leendert H J LooijengaKatja P Wolffenbuttel
Best Practice & Research. Clinical Endocrinology & Metabolism
Leendert H J LooijengaKatja P Wolffenbuttel
© 2022 Meta ULC. All rights reserved